MedPath
NMPA Approval

Osalmid Tablets

国药准字H41020747

March 24, 2025

Drug Information

柳胺酚片

片剂

0.25g

化学药品

March 24, 2025

Company Information

Applicant Company

安阳高新区井冈大街北段路东

Manufacturing Company

安阳市高新技术开发区井冈大街2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

柳胺酚片 - NMPA 批准文号 | MedPath